Identification of antigens presented by MHC for vaccines against tuberculosis
Mycobacterium tuberculosis (M.tb) is responsible for more deaths globally than any other pathogen. The only available vaccine, bacillus Calmette-Guérin (BCG), has variable efficacy throughout the world. A more effective vaccine is urgently needed. The immune response against tuberculosis relies, at...
Autori principali: | Bettencourt, P, Müller, J, Nicastri, A, Cantillon, D, Madhavan, M, Charles, PD, Fotso, CB, Wittenberg, R, Bull, N, Pinpathomrat, N, Waddell, SJ, Stylianou, E, Hill, AVS, Ternette, N, McShane, H |
---|---|
Natura: | Journal article |
Lingua: | English |
Pubblicazione: |
Springer Nature
2020
|
Documenti analoghi
Documenti analoghi
-
Identification of antigens presented by MHC for vaccines against tuberculosis
di: Bettencourt, P, et al.
Pubblicazione: (2020) -
Identification of novel mycobacterial antigens presented by MHC-I and -II by immunopeptidomics for vaccines against tuberculosis
di: Bettencourt, P, et al.
Pubblicazione: (2019) -
Identification and evaluation of novel protective antigens for the development of a candidate TB subunit vaccine
di: Stylianou, E, et al.
Pubblicazione: (2018) -
A five-antigen Esx-5a fusion delivered as a prime-boost regimen protects against M.tb challenge
di: Stylianou, E, et al.
Pubblicazione: (2023) -
Using an effective TB vaccination regimen to identify immune responses associated with protection in the murine model
di: Pinpathomrat, N, et al.
Pubblicazione: (2021)